chrisvoncsefalvay/vaers-outcomes huggingface dataset:
woke up feeling really crappy; dry cough for several hours that subsided periodically; felt nauseous; had chills last night; she felt okay, but had some fatigue; low fever max 98.6; massive headache; pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (woke up feeling really crappy), COUGH (dry cough for several hours that subsided periodically), NAUSEA (felt nauseous), CHILLS (had chills last night) and FATIGUE (she felt okay, but had some fatigue) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 061E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included BUPROPION and BUSPIRONE for an unknown indication.    On 05-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Oct-2021, the patient experienced VACCINATION SITE PAIN (pain at injection site). On 06-Oct-2021, the patient experienced FEELING ABNORMAL (woke up feeling really crappy), COUGH (dry cough for several hours that subsided periodically), NAUSEA (felt nauseous), CHILLS (had chills last night), FATIGUE (she felt okay, but had some fatigue), PYREXIA (low fever max 98.6) and HEADACHE (massive headache). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] for Headache, at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (woke up feeling really crappy), NAUSEA (felt nauseous), CHILLS (had chills last night), FATIGUE (she felt okay, but had some fatigue) and PYREXIA (low fever max 98.6) outcome was unknown and COUGH (dry cough for several hours that subsided periodically), VACCINATION SITE PAIN (pain at injection site) and HEADACHE (massive headache) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 98.6 (High) 98.6.
On Monday March 8th I went to the Pharmacy to get the Johnson & Johnson Covid vaccine under the new 1b guidelines. I am a 62 year old white male with type 1 diabetes, insulin dependent for the past 49 years. I filled out the question form I was presented by the staff and then was given a dose of the J&J vaccine. This vaccine was administered at approx. 1:30 p.m. I was asked to wait 15 minutes to see if I had and acute reaction, following none, I was told I could leave. There rest of the day I was fine. I went to bed at 11:00 p.m. and within 15 minutes I was cold, shaking and sick on my stomach. I took my temp and it was 100.2 F My O2 sat was 95% and heart rate was 120 with feelings of palpitations from time to time. I went to the bathroom and stayed there the rest of the night with frequent vomiting and loose stool. Stomach cramps all night long. Several BGL were taken and even with an insulin pump I was not able to lower my 299 level for over the next 24 hours of repeated bolus. I was finally able to stop dry heaves and fall asleep for moments at a time around 5:00 a.m. My temp finally broke around 11:00 a.m. the next day Tuesday. I had a headache this entire time. I called hospital ( Ask a Nurse ) on Tuesday morning around 8:00 a.m.and enquired about side effects for this vaccine and effects on a type 1, they basically told me to go to the ER or Clinic and be seen by a Physician. I choose not to do either, but to monitor myself and see how the rest of the day went. The first time, other than a headache and complete body soreness my vitals and BGL, were WNL,  was late Tuesday evening around 7:00 p.m. This was a horrible set of side effects. Onset was within 11 hours from injection. No warning for type 1 people to be careful for the possibilities of increased BGL. Today is Wednesday March 10th, and my vitals have remained WNL, but I still have a mild headache and body soreness, some maybe from the vaccine but I believe mostly from the throwing up. Today is March 11th, my vitals are still WNL and BGL is in target. BGL control is responsive to pump therapy now. The past 2 nights I have awoken in a cold soaking sweat that cannot be tied to a low BGL. My body is somewhat still soreness.
she is/was breastfeeding; Extra dose administered; This non-serious case was reported by a consumer via call center representative and described the occurrence of breast feeding in a female patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis.   Previously administered products included Tdap Vaccine (prior dose was received in September 2019). Concurrent medical conditions included bell's palsy.   On 18-JUN-2023, the patient received the 2nd dose of Boostrix. On 18-JUN-2023, an unknown time after receiving Boostrix, the patient experienced extra dose administered (Verbatim: Extra dose administered). On an unknown date, the patient experienced breast feeding (Verbatim: she is/was breastfeeding). The outcome of the breast feeding and extra dose administered were unknown.   It was unknown if the reporter considered the breast feeding to be related to Boostrix.     It was unknown if the company considered the breast feeding to be related to Boostrix.   Additional Information: GSK Receipt Date: 17-JUN-2023 The patient self-reported this case. The reporter was consumer. The patient reported that she developed Bell's Palsy recently, it was developed about 2 days before she delivered her son. The patient did not believe that her prior shot with the Tdap vaccine in 2019 had anything to do with her developing Bell's Palsy, she attributed the Bell's Palsy to being pregnant. The patient also knew that the disease control recommended that pregnant women should be vaccinated during the third trimester of pregnancy with Tdap however, the patient did not receive the vaccine during pregnancy because no one told her to get it. The patient did get a dose of Boostrix. The patient was no longer pregnant on 18th JUN-2023 but she was breastfeeding.  The patient did not have the lot number available. The reporter stated that getting the Boostix shot did not negatively affect her Bells Palsy.  The patient said prior to getting the shot she was about 70 percent better from the Bells Palsy and now she was about 90 percent better.  The face and tongue and speech were a lot better.
12-1-16 received PREVNAR 13 in left arm. Chills, swelled, redness. Went to doctor 12-20-16 and received a steroid cream. May get antibiotic if not better in a few days.
Vaccine exposure via breast milk; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (Vaccine exposure via breast milk) in a male patient of an unknown age exposed to mRNA-1273 (Moderna COVID-19 Vaccine) , while the mother received the product for Vaccine exposure via breast milk.     No Medical History information was reported.    On an unknown date, the mother received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. The mother's last menstrual period was on 18-Aug-2020 and the estimated date of delivery was 25-May-2021. On an unknown date, the patient was diagnosed with EXPOSURE VIA BREAST MILK (Vaccine exposure via breast milk). The delivery occurred on an unknown date, which was reported as Full-term. For neonate 1, the birth weight was 3600 grams (7lbs 15oz). The outcome was reported as Term Birth w/o Complications. At the time of the report, EXPOSURE VIA BREAST MILK (Vaccine exposure via breast milk) had resolved. Unknown          No concomitant products were reported. There were no pregnancy related complication or other acute illnesses.  No treatment information provided.   This case was linked to MOD-2021-010771 (Parent-Child Link).   See case MOD-2021-010771 for details regarding the Parent case.
No additional AE reported; Nurse reported two temperature excursions on multiple refrigerated vaccines.  There was a prior excursion on 5/3/2022 and a recent excursion on 5/26/2022.  She said it was very likely all vaccines had been administered since the excursions occurred.; This spontaneous report has been received from a nurse, concerning a 06-months-old female patient. No information was provided regarding the patient's pertinent medical history, concomitant medications, concurrent conditions, and previous drug reactions or allergies.  On 03-MAY-2022, the rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot #U026664 experienced a temperature excursion of 47.3 Fahrenheit degrees (F) for 5 minutes, if a digital data logger was involved was not reported (product storage error).   Consequently, on 05-MAY-2022, the patient was vaccinated with rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot number reported as U026664 confirmed as valid, expiration date reported and stablished as 24-FEB-2023) administered orally as prophylaxis (formulation, strength, dose, vaccination scheme were not provided) (product storage error). No additional adverse events (AE) reported (no adverse event).; Sender's Comments:  US-009507513-2206USA001582: US-009507513-2206USA001583: US-009507513-2206USA001584: US-009507513-2206USA001585: US-009507513-2206USA001586: US-009507513-2206USA001587: US-009507513-2206USA001588: US-009507513-2206USA001589: US-009507513-2206USA001590: US-009507513-2206USA001591: US-009507513-2206USA001592: US-009507513-2206USA001593: US-009507513-2206USA001594: US-009507513-2206USA001595: US-009507513-2206USA001596: US-009507513-2206USA001597: US-009507513-2206USA001598: US-009507513-2206USA001599: US-009507513-2206USA001600: US-009507513-2204USA001865: US-009507513-2204USA001998: US-009507513-2204USA002052: US-009507513-2204USA001952: US-009507513-2206USA001103:
Given in less than 4 months after their 1st booster shot. No signs and symptoms to report at this time.
Information regarding Prevenar (pneumococcal 7-valent conjugate vaccine (diphtheria crm197 protein) injection) was received from a consumer regarding a 16 month old male patient who experienced a golf ball sized red and purple area at the injection site. At 16 months of age, the patient received the third dose on 12/6/2005. The patient has a past history of a neutrophil count problem at birth, The patient received two prior doses of Prevnar without incident. Indication for Prevnar was immunisation. Product was administered on 12/6/2005. Dose regimen was 1 dose 1 time per day intramuscular. Concomitant therapy included Zantac (ranitidine Hydrochloride), Prevacid (lansoprozaole) and Flu shot (influenza virus vaccine polyvalent). On 12/08/2005, the patient developed a golf ball sized red and purple area on his upper right arm at Prevnar injection site (injection site inflammation), injection site erythema, injection site discoloration. The area was described as warm to the touch and hard, with an open spot (injection site warmth, injection site induration. The patient visited the pediatrician who believed it was an infection and treated the patient with an antibiotic (injection site infection). The reporter stated that the area has improved though there is still a red and purple appearance and a hardness. Additional information has been requested.
Arthritis in joints. Rolling joint pain and inflammation all over the body. So bad I can?t walk or move.
pt recvd vax & had fever of 100; diarrhea; v; severe headache w/ muscle aches; dry cough;
Initial severe pain at injection site. It continued and spread from the left upper arm to the shoulder and upper back. Arm became unusable and was hanging out of the shoulder joint. Still very limited in use and constantly painful, lost muscle in area.
Fever, (101F) chills, cramping, headache, vomiting, lethargy  Itching and swelling at site of shot
1hr p/vax 26SEP95 pt began crying unconsolably; sxs persisted about 12hrs;
Soreness at injection site; This is a spontaneous report from a contactable nurse (patient).  A 24-years-old female patient started to the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number: EL1284, intramuscularly on 30Dec2020 (at the age of 24-years-old) as a 1 single dose in the left arm for COVID-19 immunization. Medical history included type one diabetic and celiac disease. The patient had a medical history of allergies to iodine, shellfish, seafood and fish. Concomitant medications was unknown. The most recent COVID-19 vaccine was administered in the hospital.  The patient was not pregnant at the time of vaccination.   Prior to vaccination, the patient was not diagnosed with COVID-19.  On unspecified date, the patient experienced soreness at injection site.   The soreness at injection site did not result in death, was not life-threatening, did not cause/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect.  No treatment was received for the event.  Outcome of the event Soreness at injection site was recovered. Since the vaccination, the patient has not been tested for COVID-19.
I tested positive for COVID-19 on 11/25/22. I had cough, tickle in my throat, congestion, headache, and a fever. I was not prescribed medications, but I took vitamins, AIRBORNE, BENADRYL, acetaminophen, and acyclovir. I started taking acyclovir because when I get sick, sometimes I break out in Shingles when I get sick. I am feeling better, but I am still dealing with the symptoms.
Client complained of itchiness to throat, right arm, left foot, abdomen, and right temple. Denied any difficulty breath or shortness of breath. Able to drink water without difficulties. Offered Benadryl IM. Vital signs stable.  B/P 110/56 HR 74 RR 18 O2 Sats 100%. No distress noted.
Pain in mus. in left arm - continuing as when arm is reached in a stretch position (ei) high over head or behind me - daily - with use continuing still.
my periods are irregular; This is a spontaneous report from a contactable other healthcare professional. A 33-year-old, non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL0142) via intramuscular route of administration in the right arm on 10Jan2021 at 09:00 (at the age of 33-year-old) as a single dose for COVID-19 immunisation. No relevant medical history reported. The patient did not receive any other medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Feb2021, the patient reported that since she received the COVID vaccine series her menstrual cycle was disrupted. The patient reported that she noticed a big change for two complete cycles. The patient reported that her period cycle was regular and was of 28 days. The patient reported that her ovulation occurred earlier and her periods were irregular. The patient also reported that her period arrived a day or two early and she had 2 normal days of bleeding and then it went away for over 24 hours, followed by medium flow the following day. The patient reported that this was abnormal for her. The patient also reported that she was going to contact her physician for the same but saw information about other women who experienced changes in their menstrual cycle after the vaccine. The patient reported that she had no other symptoms but she thought it was important to report this. No therapeutic measures were taken as a result of the reported event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event menstrual cycle was irregular was resolved with lasting effects on an unknown date in 2021. The patient received subsequent second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on an unknown date in 2021, as a single dose for COVID-19 immunisation  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Pt noted arm stiffness/soreness; couldn't raise arm above head x 2 days. Dr told her to apply heat to area which helped somewhat. Also reported nausea, loss of appetite and vomiting x 2. Feels better on 10/1/13 at time of report. Saw doctor for pain meds over weekend.
12/10/15 client and daughter walked in to PH office. Daughter was reported changes with vision that she thought was due to LTBI meds. While reporting this, daughter translated that her mother had history of November immunization at public health clinic and felt ill day after vaccination. Lasted two -three days weak, dizziness, pain above and below eyes. No yellowing in eyes. No redness or drainage noted. No secretion in nares. No cough BP 126/84. Daughter had called Dr who did not think it was medicine but advised to hold until 12/14. Consulted by phone. Attempted to make clinic appt as generally unwell and uninsured. No appts today. Daughter works tomorrow but off Monday. PHN will work to get clinic Monday if still unwell. Will enter in VAERS for last immunizations.
Pt received Janssen Covid vaccine on 3/11 and then again on 3/23. This was discovered by the  homeless shelter staff on 3/24 and reported to HC provider. Pt denies any symptoms.
Inadvertent administration of Tdap when pt in need of DTaP due to clinical staff error on 3/10. Pt then on 3/11 developed nodule, swelling and erythema at site of vaccination. On 3/17 pt also developed full body maculopapular rash.
No reaction as of now. IMZ was given outside of the 12 hour window, the vaccine was expired
he was flushed; light headed; tingling around mouth; 3-4 minutes after my blood pressure was high; heart rate was 120 or so; This is a spontaneous report from a contactable physician (patient). A male patient of an unspecified age received the first dose of BNT162B2 (lot number unknonwn), via an unspecified route of administration, in Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient stated that he received the first dose of the vaccine 11 days ago in Dec2020 and had a reaction. He stated probably 3 minutes after when he was getting ready to leave the area he was flushed and light headed and tingling around mouth. The staff in the area sat him down and 3-4 minutes after his blood pressure was high and heart rate was 120 or so. Those symptoms lasted about 10 minutes and went away on their own and he did not get epi pen or Benadryl. The patient's vital signs were normal after an hour or so and there was no intervention at any point and have had no issues subsequently. He stated that they said it wasn't technically an anaphylactic reaction but that it is hard to put a name to this description. The outcome of the events was recovered in Dec2020.  Information on the lot/batch number has been requested.
Between 3/9 and 3/22 patient experienced unilateral ankle swelling. Dr prescribed furosemide with no effect. Patient did doppler US and other screening for blood clot and did not find a DVT/peripheral clot. Swelling has since decreased. Patient was taking meloxicam for shoulder pain x 1 week around the time of the vaccination.
Within 3 hours of Hep A and BEXSERO patient developed change in mental status, headache -> progressed to vomiting and numbness.
Shoulder (joint) and arm pain. Shooting pain when lifting arm, or crossing the body with arm. Ongoing since time of flu shot on November 4, 2011. Starting physical therapy 12/7/11.
Received shot, no abnormal pain with injection. Within 3 mins, my left arm went numb, cold and then varied between numb and tingly from just below the injection site to my fingertips. This is still present and remains unchanged after 24 hours. Also, i had a sensation of a rolling needle in  straight line from left shoulder to my right shoulder, then up my neck from my shoulder line to my hair line. That was only once immediately after the first arm numbness, within the 3 mins after the shot. I sat down, I was not anxious or overly worried. I alerted the pharmacist who requested I stay additional time. After 1o -15 mins my face went numb and then tingly on the left side from jaw line to midway my chin and to my nose level.  The tingly stopped after a few minutes on my face but the numb feeling (similar to a feeling of being numbed at the dentist that has worn off some). I can smile, and control my movements and tehre is no drooping, just feels numb. This remains after 24 hours though not as pronounced. I went straight to the ER at the advice of the pharmacist and the nurse on call at my primary doctor's office (called afterhours on call).  I was checked for an allergic reaction, ruled out. I had an EKG and CT scan, which were clear. My blood work was clear. I was diagnosed with an adverse reaction to the vaccine. It was recommended that I follow up with my physician and have a possible MRI if symptoms remained after a few days. I have requested an appt with my physician and am still experiencing the same symptoms.  Today, my left side (same side as vaccination site and symptoms), my neck,  more of my face, my underarm area and area over my ribs, have tingled off and on at an intense rate. I have puffiness and tenderness over my rib area on my left side that was not present until today. I am not sore, I do not feel sick.   The only tender spot is across my ribs. My vision is good, no headache, no nausea. I was not sick, or experiencing any of these symptoms prior to the vaccination.
First dose without incident. 18Jan2021 6:40am 2nd dose - 12hr later felt blah, 24hrs later extremely dizzy with moderate headache and body aches.  then at 4am 20Jan2021 (right around 48hrs), I had erythema with a blister on left lateral side around rib region 8-10 with itching and burning. This improved to no erythema and this morning (21Jan2021) only 3 blisters with mild discomfort.
Narrative: Pt received the vaccine approx 2-3 min later c/o tongue swelling unable to complete sentences. Denied SOB, rash, or arm swelling. Pulse ox 100%, pulse rate 80"s. declined epi pen sent to the ED for evaluation
Got Shingles from the Shingles vaccine/ suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got Shingles from the Shingles vaccine/ suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   The reporter considered the vaccination failure and shingles to be possibly related to Shingles vaccine.     The company considered the vaccination failure and shingles to be possibly related to Shingles vaccine.   Additional Information: GSK Receipt Date: 18-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that he or she experienced shingles from the Shingles vaccine. According to narrative verbatim the causality was conservatively captured as possible. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.